PAM
AVXL icon

PVG Asset Management’s Anavex Life Sciences AVXL Stock Holding History

PVG Asset Management’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$848K Sell
327,344
-200
-0.1% -$592 0.49% 59
2026
Q1 		$819K Buy
327,544
+111,249
+51% +$482K 0.48% 59
2025
Q4 		$770K Buy
216,295
+83,147
+62% +$509K 1.64% 16
2025
Q3 		$1.19M Buy
133,148
+21,703
+19% +$220K 4.36% 2
2025
Q2 		$1.03M Buy
111,445
+28,837
+35% +$246K 3.5% 4
2025
Q1 		$709K Buy
82,608
+4,118
+5% +$38.9K 3.09% 9
2024
Q4 		$843K Buy
78,490
+65,485
+504% +$504K 3.99% 5
2024
Q3 		$73.9K Buy
+13,005
New +$75K 0.3% 40

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

PVG Asset Management's AVXL Position: Q2 2026 in Review

PVG Asset Management reduced its Anavex Life Sciences (AVXL) stake by 0.06% in Q2 2026, selling an estimated $592 and leaving 327,344 shares worth $848K. The position accounts for 0.49% of the portfolio, ranked #59.

PVG Asset Management first reported a position in AVXL in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.19M in Q3 2025. 180 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • PVG Asset Management held 327,344 shares of Anavex Life Sciences worth $848K as of Q2 2026.
  • PVG Asset Management sold 200 Anavex Life Sciences shares in Q2 2026, an estimated $592.
  • Anavex Life Sciences made up 0.49% of PVG Asset Management's portfolio in Q2 2026, its #59 holding.
  • PVG Asset Management first reported a position in Anavex Life Sciences in Q3 2024 and has held it in 8 quarters since.
  • PVG Asset Management's Anavex Life Sciences position peaked at $1.19M in Q3 2025.
  • 180 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on PVG Asset Management's 13F filing for Q2 2026, filed 1 Jul 2026.